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Abstract
NKT cells contribute to the modulation of immune responses and are believed to be important in the pathogenesis of
autoimmune and infectious diseases, as well as cancer. Variations in the composite NKT cytokine response may determine
individual disease susceptibility or severity. Due to low frequencies in peripheral blood, knowledge of the breadth of ex vivo
human NKT cell functions has been limited. To bridge this gap, we studied highly purified NKT cells from PBMC of healthy
donors and assessed the production of 27 effector functions using sensitive Elispot and multiplex bead assays. We found
the ex vivo human NKT cell response is predominantly comprised of the chemokines MIP1-a, and MIP1-b as well as the Th1
cytokines IFN-c and TNF-a. Although lower in magnitude, there was also significant production of IL-2, IL-4, and perforin
after mitogen stimulation. Surprisingly, little/no IL-5, IL-6, IL-10, or IL-13 was detected, and no subjects’ NKT cells produced
IL-17. Comparison of the NKT functional profiles between age-matched male and female subjects revealed similar IL-4
responses, but higher frequencies of cells producing IFN-c and MIP1-a, from males. There were no gender differences in the
circulating NKT subset distribution. These findings implicate chemokines as a major mechanism by which NKT cells control
responses in humans. In addition, the panoply of Th2 and Th17 cytokine secretion by NKT cells from healthy donors may not
be as pronounced as previously believed. NKT cells may therefore contribute to the gender bias found in many diseases.
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Introduction
NKT cells are a rare subset of T lymphocytes with functional
characteristics spanning both the innate and adaptive arms of an
immune response. NKT cells recognize glycolipid antigens
presented via the non-classical MHC CD1d, and can also be
activated via Toll like receptor engagement[1]. Populations of
NKT cells secrete Th1 and Th2 cytokines[2–10]; mouse NKT
cells also produce IL-17[11–14], a cytokine implicated in the
pathogenesis of many autoimmune diseases[15]. While human
CD56+TCRb
+ cells secrete IL-17[13], whether human NKT cells
secrete this Th17 cytokine ex vivo is unclear. Human NKT clones
have been shown to down-regulate IL-17 production from
memory CD4+ T cells[16]. NKT cells contribute to responses
against foreign, self, and tumor antigens, and are thought to play a
pivotal role in disease progression, including cancer metastasis,
where they are now targeted in clinical trials[17]. Paradoxically,
NKT cells combat disease progression in certain cases but are
associated with poor outcomes in others[2,18–32]. These
seemingly conflicting data reflect nuances of NKT cell biology
that are currently unknown.
In order to establish how NKT cells modulate immune
responses, it is first necessary to determine the breadth and
relative magnitude of effector functions exerted ex vivo by this T cell
population in humans. However, due to the inherent technical
difficulties in studying these rare populations (usually less than
0.1% of lymphocytes in PBMC)[9], there is sparse data regarding
their patterns of effector functions ex vivo. Previous ex vivo functional
profiling studies used multi-dimensional flow cytometry for
simultaneous discrimination and assessment of up to ten NKT
cell functions, with reported IL-4, IL-5, IL-10, and IL-13 secretion
from ,10–20% of total NKT cells[3], and enrichment of Th2
cytokines (IL-4, IL-13) within the CD4+ subset[3,8,9]. Given the
paucity of circulating NKT cells, and alteration of CD4 expression
after PMA stimulation[33], flow-based cytokine analysis of bulk
PBMCs may provide only limited sensitivity and resolving
capacity.
Several diseases reportedly mediated by NKT cells are also
strongly influenced by gender. NKT cells influence disease course
in several autoimmune disorders[34] as well as tumor progres-
sion[35], two types of diseases that also present strong gender
biases. For example, systemic lupus erythematosus (SLE),
myasthenia gravis (MG), and rheumatoid arthritis (RA) are more
common in women than men[36]. Gender specific differences in
gene profiles of tumor samples from lung cancer patients have also
been reported[37]. Also, IFN-c secretion from mouse NKT cells is
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differences in human NKT function is currently unknown.
In this study, we sought to define the scope and magnitude of
the ex vivo functional capacity of human NKT cells and further
assess for gender-specific differences. To answer these questions,
we purified NKT cells from freshly isolated PBMC of healthy
donors and determined the production of 27 different analytes by
sensitive Elispot and Luminex assays. Additionally, eight-color
flow cytometry was performed on PBMC from all donors to
compare the NKT cell subset distribution between males and
females.
Results
Study Subjects, NKT gating strategy, and purity of sorted
NKT cell populations
Due to their low numbers in human peripheral blood, our
understanding of the ex vivo functional capabilities of NKT cells is
limited. To better elucidate the range of cytokine, chemokine, and
cytotoxic-associated NKT responses directly ex vivo, we purified
this unique T cell population using flow cytometric cell sorting.
The subjects in our cohort had a wide range of NKT cell
frequencies (1.010 to 0.009 per cent of lymphocytes) and the sort
purities were high for all subjects, averaging greater than 99
percent (Table 1). We collected approximately 100 ml of fresh
blood from 12 healthy donors (six males and six females). We
discriminated NKT cells via expression of CD3, va24, and a
CD1d-antigen loaded tetramer to ensure accurate gating[8,9,39]
(Figure 1).
Single cell resolution of the ex vivo effector functions of
human NKT cells via Elispot assays
Human NKT cells have been reported to make several Th1 and
Th2 cytokines, with the relative magnitude of each potentially
influencing disease course. To compare the frequencies of NKT
cells exerting a broad spectrum of effector functions, we performed
14 different elispot assays, including Th1 cytokines (IL-2, IFN-c,
TNF-a, TNF-b), Th2 cytokines (IL-4, IL-5, IL-6, IL-10, IL-13),
the Th17 cytokine IL-17, chemokines (MIP1-a, and MIP1-b), and
cytotoxic effector molecules (perforin, granzyme B) (Figure 2A).
Serial dilutions of sorted cells were performed for all assays in the
majority of subjects (cell number permitting); the resulting linear
relationship between input cell number and spot number in the
elispot assay confirms each spot accurately represents one
cytokine-producing cell (Figure 2B).
Elispot assays detect NKT cells secreting seven of the 14
functions measured in response to mitogen stimulation
We next determined the total frequencies of NKT cells exerting
14 different functions ex vivo for all subjects in the cohort. When
comparing the number of spots from unstimulated and stimulated
wells, we found significant induction of spots by PMA and
Ionomycin for seven of the 14 analytes, including IL-2, IL-4, IFN-
c, TNF-a, MIP1-a, MIP1-b, and Perforin (Figure 3). IL-5, IL-6,
IL-10, IL-13, and IL-17-producing NKT cells were not detected
following mitogen exposure, but were observed in the positive
controls (Figure 3).
Luminex assays confirmed little/no IL-5, IL-6, IL-10, and
IL-13 production and a lack of IL-17 secretion from the
NKT cells of healthy donors
To confirm our elispot findings and expand our analysis of
NKT cell functions, we next performed 26-plex Luminex assays
on supernatants from one to two day cultures of freshly sorted
peripheral blood NKT isolates. As expected, we found significant
production of the cytokines detected by our elispot experiments in
response to PMA and Ionomycin, (IL-2, IL-4, IFN-c, TNF-a,
MIP1-a, MIP1-b) (Figure 4A) for all five subjects (Figure 4A and
4B). Also, overall, we found extremely low levels of IL-5, IL-6, IL-
10, or IL-13 in the subject supernatants. One exception was found
for subject 1, where IL-13 secretion was more than 10 fold over
the assay’s limit of detection (Figure 4A).
Measurement of IL-17 via Luminex assays revealed this
hallmark Th17 cytokine was not present in culture supernatants
from any of the donors (Figure 4A and 4B). These data, together
with our elispot results, conclusively show a lack of IL-17
production ex vivo from the NKT cells of all donors in our cohort.
NKT functional profiles of age-matched subjects reveal a
significant Th1 bias in male donors
As there are noted sex differences in susceptibility to many
diseases whose progression may be influenced by NKT cells, we
Table 1. Donor information with sorting purity.
Donor Sex Age Ethnicity NKT frequency (% lymphocytes) Post-Sort Purity
1 M 29 Asian 1.010 100%
2 F 22 Caucasian 0.660 99.9%
3 M 31 Asian 0.600 99.9%
4 F 24 Caucasian 0.590 99.8%
5 M 32 Caucasian 0.410 100%
6 M 30 Caucasian 0.240 99.8%
7 M 32 Caucasian 0.110 98.5%
8 F 29 Caucasian 0.098 99.5%
9 F 31 Caucasian 0.071 97.5%
10 F 23 Caucasian 0.057 99.4%
11 M 33 Caucasian 0.016 98.1%
12 F 30 Asian 0.009 96.7%
Subjects are listed in descending NKT cell frequency. Sort purities are expressed as percent of CD3+ T cells.
doi:10.1371/journal.pone.0015412.t001
Ex vivo Human NKT Cell Functions
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function profiles. The frequencies of NKT cells secreting IL-2 and
IL-4 after mitogen stimulation were similar between male and
female subject groups (Figure 5A). However, males had signifi-
cantly greater numbers of circulating NKT cells that produce the
Th1 cytokines IFN-c and MIP1-a in response to PMA and
Ionomycin than their female counterparts (Figure 5A). The
number of TNF-a–secretingNKT cells varied considerably
amongst male subjects, but was comparatively lower amongst all
female subjects, with less than 17% of NKT cells secreting this
major Th1 cytokine after stimulation (Figure 5A). As our elispot
assays provide information on the number of cells making a
cytokine, but not the quantity cytokine made, our next question
was whether male-derived NKT cells also secrete a higher ratio of
Th1:Th2 cytokines. To address this, we compared the cytokine
concentration values derived from our Luminex assays. We found
higher mean ratios for Th1 cytokines IFN-c, MIP1-a, and TNF-a
to IL-4 amongst male subjects as compared to the female group,
(49:6, 72:7, and 13:2, respectively) (Figure 5B). In contrast, we
found no apparent gender difference when comparing the ratio of
IL-4 to the cytokines IL-2 or GM-CSF, neither of which is
exclusively secreted by Th1 cells (Figure 5C). Taken together,
these data demonstrate a Th1 bias of ex vivo NKT cell functions in
males.
No differences in the subset distribution of circulating
NKT cells between men and women
Subsets of human NKT cells have been reported to exert
different functional patterns, with CD42 CD82 (DN) cells
secreting only Th1 cytokines, while the CD4+ CD82 (SP) fraction
produces both Th1 and Th2 cytokines [3,8,9]. As our data found
gender-related differences in the effector function profiles of the
circulating NKT cell compartment (Figure 5A–C), we next sought
to determine whether this functional divergence was due to
differences in circulating NKT subset distributions. Using flow
cytometry, we measured both the total NKT frequencies and the
percentage of CD4, CD8, CD69, CD56, and CD161 NKT
subsets within PBMC from the same blood draw as our sorted
samples from all subjects. We found no significant differences for
either total NKT frequencies (Figure 6A) or the percentages of
CD4+ CD8+ (DP), CD4+ CD82 (SP), CD42 CD8+ (SP), CD42
CD82 (DN), CD69+, CD161+, or CD56+ subsets between the
male and female subject groups in our study (Figure 6B).
Discussion
This study measured the ex vivo functional profiles of purified
human NKT cells and demonstrated that this T cell population
exerts a lower Th2 response, both in magnitude and diversity,
than previously reported. Also, IL-17 was not detected from any
NKT cell populations in this study. In addition, we found that the
chemokines MIP1-a and MIP1-b were two of the most
predominant factors secreted from the NKT cells of all subjects
in our cohort. These experiments also revealed that male NKT
cells are more Th1-biased than their female counterparts.
Our data revealed the significant production of some factors not
previously associated with NKT cell effector function profiles. For
example, the NKT cell populations from the vast majority of
subjects in our cohort secreted the chemokines MIP1-a and MIP1-
b(Figures 4, 5), at levels similar to IFN-c (Figures 3, 4). MIP1-a
and MIP1-b are potent inflammatory agents that attract both
monocyte and lymphocyte subsets. NKT cells often influence
Figure 1. NKT gating strategy and an example of sorting purity. PBMC were first gated on lymphocytes, and NKT cells were visualized as
CD3+,v a24+ and CD1d-PBS57 tetramer+. The percentage of NKT cells within the CD3 gate is shown in the far right plots. An example of pre-and
post-sort plots from one representative donor are shown. Abbreviations: FSC-A, Forward Scatter Area; SSC-A, Side Scatter Area; FSC-H, Forward
Scatter Height.
doi:10.1371/journal.pone.0015412.g001
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PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15412Figure 2. Measurement of the ex vivo effector fuctions of purified NKT cells by elispot assays. Determination of the frequencies of NKT
cells exerting 14 different effector functions via elispot assays. (A) Representative images of elispot wells with either sorted NKT cells with no
stimulation, sorted NKT cells with PMA and Ionomycin, or total PBMC with PMA and Ionomycin (positive controls). (B) NKT cell dilution results from
two donors. Each symbol represents one effector function.
doi:10.1371/journal.pone.0015412.g002
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Therefore, future studies to determine whether NKT cells control
dendritic cell recruitment via these chemokines is of high interest.
Other factors, including eotaxin, IP-10, and IL12p70 were found
at low but detectable levels in the NKT culture supernatants from
most donors in this study. Due to the low amounts measured, these
findings may be due to a minute fraction of contaminating (non-
NKT) cells; further experiments are necessary to confirm the NKT
specificity of these analytes. Further exploration of these factors
could lead to a greater understanding of how NKT cells influence
disease onset and pathogenesis. Also, the NKT-specific expression
of these analytes may be novel biomarkers of disease states and
thus provide valuable tools for predictive diagnostics as well as new
therapeutic targets.
Our results found little/no IL-5, IL-6, IL-10, and IL-13 secreted
by NKT cells from the healthy donors in our study (Figures 2, 3,
4). These results are in contrast with some previous flow
cytometric studies[3,8]. As flow cytometric intracellular staining
detects production of cytokines, and elispots measure release of
proteins from cells, it is possible that these cytokines are modified
post-translationally within NKT cells to inhibit their secretion.
Alternatively, performing multiparameter intracellular flow cyto-
metric analysis on these rare cells could result in artifacts within
the Th2 cytokine gates, especially when data is generated from low
event counts and imprecise NKT gating. Taken together, our
Elispot and Luminex bead array data implicate IL-4 as the
predominant Th2 cytokine secreted by circulating human NKT
cells. We therefore contend that IL-4 should be a major target
when considering therapeutic immuno-modulation of NKT cells
to control inflammatory disease course.
Another cytokine that was not detected from any NKT cell
populations in our study is IL-17 (Figures 2, 3, 4). From these
results, we conclude that circulating human NKT cell populations
may not include a Th17 differentiated subset, unlike what has
been found in mice[11–14]. As human NKT cells specifically
suppress the Th17 arm of an immune response[16], it is possible
there are divergent roles of mouse and human NKT cells in
controlling immunity. This is important to note when performing
mouse studies of human NKT-related diseases, as the abstraction
of animal studies to human clinical trials may be misleading.
However, as our studies were performed in healthy donors, it is of
interest to determine whether IL-17-producing NKT cells are
found in diseased individuals.
We found a significant Th1 bias of the functional NKT profile
of male cells as compared to those from female donors. This
finding was evident from both assays (Elispot and Luminex assays)
revealing differences in both the relative frequencies of Th1 and
Th2 producing NKT cells and the total amount of cytokine from
each lineage secreted into the culture supernatant from mitogen
stimulated short-term cultures. These data may help explain the
gender-based propensities associated with certain diseases. Also,
we were surprised to find similar distributions of several NKT
subsets in the PBMC of our male and female groups. We therefore
propose that in vivo, the NKT cell effector function profile may be
influenced by external factors in the local microenvironment, such
as hormones or other factors. Future studies to determine whether
the functions of male and female NKT cells gain similarity after
long term culture in vitro is of interest, and may reveal novel ways
to modify NKT cell responses to direct favorable immune
responses in the host.
In summary, by using FACS-Aria cell sorting to purify freshly
isolated NKT cells from human donors and then measuring the
capacity of this unique T cell population to exert 27 different
effector functions ex vivo, we report several new observations about
this unique T cell subset that provide a more comprehensive
understanding of their functional profiles. Also, these experiments
revealed a novel functional Th1-bias of male NKT cells. Future
work to measure alteration of this functional profile in disease
states could provide novel insight into how NKT cell modulate
immune responses and influence disease pathogenesis.
Materials and Methods
Subjects
Healthy subjects were recruited by the Division of Experimental
Medicine at the University of California, San Francisco (San
Francisco, CA, USA). All subjects were at least 21 years of age at
the time of sample collection (Table 1). All samples were obtained
according to protocols approved by the Research Subjects Review
Board at UCSF. Written informed consent was obtained from all
subjects.
Human lymphocyte preparation
Blood was drawn into EDTA tubes and PBMC were isolated
within 16 hours of collection using ficoll-hypaque, washed twice
with PBS, and resuspended in FACS buffer (PBS with 0.5% BSA
and 2 mM EDTA) for staining.
Fluorescent antibodies and tetramers
For the sorting and determination of circulating NKT subsets,
the following reagents were used: PE-labeled CD1d-tetramer
loaded with PBS57 from the NIH Tetramer Facility (located at
Emory University, Atlanta, GA, USA). Other reagents used in the
phenotypic analysis of PBMC include: anti-CD3 ECD and anti-
va24 biotin (Beckman Coulter, Fullerton, CA, USA) and
Streptavidin-Qdot 655 (Invitrogen, Eugene, OR, USA); anti-
CD56 PE-Cy7, anti-CD161 APC, and anti-CD4 Alexa 700 (BD
Biosciences, San Jose, CA, USA); and anti-CD8 Qdot 605
(UCSF), and Amine Aqua was used for live/dead discrimination
(Invitrogen, Eugene, OR, USA).
Figure 3. Total frequencies of NKT cells exerting different
effector functions ex vivo from healthy donors. The data is
expressed as box and whisker plots, with the median for all subjects
shown as the center line, the box representing the 25–75 percentile,
and the lines showing the range of the data. Statistically significant
differences between unstimulated (white boxes) and stimulated (grey
boxes) wells (p,0.05) are noted with an asterisk. Eight subjects were
included in this analysis.
doi:10.1371/journal.pone.0015412.g003
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e15412Figure 4. 26-plex Luminex assays reveal the ex vivo functional bio-signature of human NKT cells. The levels of 26 different analytes were
measured from culture supernatants of pure NKT cell populations, either with or without PMA and Ionomycin stimulation. In (A), each plot represents one
individual, withthe donor number noted at the top. The limitsof detection of each analyte areshown ingray bars, and arelisted in thematerials and methods.
A significant level of analyte (as defined in the materials and methods) from either unstimulated and/or stimulated culture supernatants is noted with an
asterisk. Symbols on the Y axis represent values to low to be given a numerical value. Note that the scale is different for the donor 1 graph (0.1–11,000).( B )T h e
percentage of the five subjects whose culture supernatants (either unstimulated, stimulated, or both) gave a significant signal for each analyte.
doi:10.1371/journal.pone.0015412.g004
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PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15412Figure 5. Th1 bias of NKT cells from male donors. The ex vivo effector functions of NKT cells from male and female subject groups were
compared. (A) The gender differences (n=6/group) in the number of cytokine producing cells detected via elispot; statistically significant differences
between groups are noted. White and grey boxes denote the male and female groups, respectively. Data is shown as box and whisker plots, with the
center line noting the median, the boxes noting the 25–75 percentile, and the lines representing the range for each group. The ratio of Th1 cytokines
(B) and non-Th1 cytokines (C) to IL-4 from pure NKT cell populations measured by the luminex assay. In (B) and (C), each circle represents one donor,
with the line noting the mean for each group.
doi:10.1371/journal.pone.0015412.g005
Figure 6. Similar distribution of NKT cell subsets between sexes. Eight-color flow cytometry was performed on PBMC samples from the same
blood draw as the sorted NKT cell populations to compare (A) the NKT total cell frequencies as a per cent of lymphocytes and (B) the CD4+ CD8+
(Double Positive, or DP), CD4+CD82 cells (CD4 SP), CD42 CD8+ (CD8 SP), CD69+; CD161+, and CD56+ NKT cell subsets between male (white boxes)
and female (grey boxes) subject groups. No significant differences were found. Data is shown as box and whisker plots, with the center line noting
the median, the boxes noting the 25–75 percentile, and the lines representing the range for each group.
doi:10.1371/journal.pone.0015412.g006
Ex vivo Human NKT Cell Functions
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Freshly isolated PBMC were incubated with CD1d-tetramer-
PBS57, anti-CD3, and anti-va24 antibodies for 30 minutes at 4uC.
Cells were then washed twice with FACS buffer (PBS with 0.5%
BSA and 2 mM EDTA), and Streptavidin-Qdot 655 was added
for 20–30 minutes at 4uC. Cells were washed twice with FACS
buffer, and sorted on a FACS-Aria flow cytometer (BD
Biosciences, San Jose, CA, USA). All cells were stained at a
concentration of 1610
7 PBMC per 100 ml of antibody mixtures in
v-bottom 96 well plates. For all sorts, doublets were excluded from
the sorted population via gating discrimination using FSC-A and
FSC-H. Purities shown reflect the percentage of CD3+ cells in the
population. The vast majority of the few non-NKT events were
found outside the FSC-SSC gate, in the area of debris (Figure 1).
Elispot antibodies
The following reagents were used for plate coating: anti-IL-2
(1:60 dilution, R&D systems, Cat. #SEL202, Minneapolis, MN
USA), anti-IL-10 (1:60 dilution, R&D systems, Cat. #SEL217B,
Minneapolis, MN USA), anti-IL-13 (1:60 dilution, R&D systems,
Cat. #SEL213, Minneapolis, MN USA), anti-IL-4 (15 mg/mL,
Mabtech, Cat.#3410-3-250, Nacka Strand, Sweden), anti-IL-5
(5–10 mg/mL, BD Biosciences, Cat.# 554393, San Jose, CA,
USA), anti-IL-6 (5 mg/mL, Mabtech, Cat. #3460-3-250, Nacka
Strand, Sweden), anti-IL-17 (5 mg/mL, ebiosciences, Cat.# 14-
7178-85, San Diego, CA, USA), anti-IFN-c (10 mg/mL, Mabtech,
Cat.# 3420-3-1000, Nacka Strand, Sweden), anti-TNFa (5 mg/
mL, Mabtech, Cat.# 3510-3-1000, Nacka Strand, Sweden), anti-
TNF-b (10 mg/mL, R&D Systems, Cat.# MAB621, Minneapolis,
MN, USA), anti-MIP1-a (10 mg/mL R&D systems, Cat.#
MAB270, Minneapolis, MN, USA), anti-MIP1b (5 mg/mL,
Mabtech, Cat.# 3495-3-250, Nacka Strand, Sweden, anti-
perforin (5 mg/mL, Mabtech, Cat.# 3465-3-1000 Nacka Strand,
Sweden), anti-granzyme B (15 mg/ml, Mabtech, Cat.# 3485-3-
1000, Nacka Strand, Sweden). The following biotinylated
antibodies were used: anti-IL-2 (1:60 dilution, R&D systems,
Cat. # SEL202, Minneapolis, MN USA), anti-IL-10 (1:60
dilution, R&D systems, Cat. # SEL217B, Minneapolis, MN
USA), anti-IL-13 (1:60 dilution, R&D systems, Cat. # SEL213,
Minneapolis, MN USA) anti-IL-4 (2 mg/mL, Mabtech, Cat.#
3410-6-250, Nacka Strand, Sweden), anti- IL-5 (2 mg/mL, BD
Biosciences, Cat.# 554491, San Jose, CA, USA), anti-IL-6 (1 mg/
mL, Mabtech, Cat. #3460-6-250, Nacka Strand, Sweden), anti-
IL-17 (1 mg/mL, ebiosciences, Cat.# 88-7876-DT, San Diego,
CA, USA), anti-IFN-c (1 mg/mL, Mabtech, Cat.# 3420-6-250,
Nacka Strand, Sweden), anti-TNF-a (2 mg/mL, Mabtech, Cat.#
3510-6-1000, Nacka Strand, Sweden), anti-TNF-b (1 mg/mL,
R&D Systems, Cat.# BAF211, Minneapolis, MN USA), anti-
Mip1a (2 mg/mL, R&D systems, Cat.# BAF270 Minneapolis,
MN USA), anti-MIP1-b (1 mg/mL, Mabtech, Cat.# 3495-6-250,
Nacka Strand, Sweden), anti-perforin (1 mg/mL, Mabtech, Cat.#
3465-6-1000, Nacka Strand, Sweden), anti-granzyme B (1 mg/ml,
Mabtech, Cat.# 3485-6-1000 Nacka Strand, Sweden).
Elispot assays
Elispot plates (#MAIPN4550; Millipore, Danvers, MA, USA)
were coated with primary antibodies for a minimum of one hour
at room temperature, and washed twice with PBS before cells were
added. The pure NKT cell populations were added in 200 mlo f
complete media; the range of the top dilutions for all donors was
3,333 to 118 cells/well. Cells were added to wells with no
stimulation (eight of the 12 donors) and/or PMA (50 ng/mL) and
Ionomycin (500 ng/mL) (12 of the 12 donors). Due to low cell
yields, four donors’ NKT cells were only added to wells with
PMA/Ionomycin. Cell number permitting, multiple dilutions were
performed for all assays to ensure accurate spot numbers
(Figure 2B). The plates were incubated at 37uC, 5% CO2 for
15–18 hours. At the end of the culture period, the plates were
washed twice with PBS and twice with PBS plus 0.1% Tween 20
(PBST), and secondary antibodies were added in PBS 0.1%
Tween 20 1% BSA (PBSTB), 50 ml/well for 45 minutes at room
temperature. Plates were then washed again twice with PBST, and
the streptavidin-Alkaline Phosphatase (1:1000 dilution, Jackson
Immunoresearch, Cat.# 016-050-084, West Grove, PA, USA)
was added in 100 ml PBSTB for 45 minutes. Plates were again
washed twice with PBST, the plastic backing was removed, and
then the plates were immersed in PBST for one hour. Next,
substrate mix was added (Vector Laboratories, Cat. #SK5300,
Burlingame, CA, USA). When blue spots were clearly visible, the
plates were washed with tap water. When plates were dry, spots
were counted using an automated elispot reader.
NKT cell cultures for supernatant collection
NKT cell populations from five donors (11,000–50,000 cells per
well) were cultured for one-two days either with or without
mitogen stimulation. At the end of the culture period, plates were
spun and supernatants were carefully collected and frozen at
220uC until thawed for Luminex analysis.
Luminex assays
Relative content and concentration for 26 analytes was
determined using cytometric multi-analyte technology. Specifical-
ly, 26-plex human cytokine/chemokine bead array kits (MILLI-
PLEX
TM MAP, Millipore Corporation, USA) were used in
conjunction with a Luminex 100 platform following manufactur-
er’s instructions. Briefly, 25 ml sample (or cytokine standard mix)
was mixed with 25 ml pooled capture beads and incubated for one
hour at RT under gentle agitation. Samples were washed by
centrifugation and then mixed with biotinylated detection
antibody. After a one-hour incubation, streptavidin-PE detection
reagent was added and the assay was carried out for an additional
30 minutes. Samples were washed, resuspended in storage buffer,
and placed at 4uC until analysis. For each analyte, a minimum of
50 bead events was collected. All samples were run in duplicate.
Raw data was analyzed using MILLIPLEX Analyst software.
Standard curves were generated (in duplicate) from lyophilized
standard provided with each kit. The concentration for each
analyte in cell supernatants was determined by interpolation from
their corresponding standard curve. The limits of detection for
each analyte are the lowest detectable point on the standard curve
+ two standard deviations. For each analyte, the limits of detection
(in pg/ml) were: eotaxin: 7.8, G-CSF: 7.7, GM-CSF: 3.5, IFN-a2:
4.0, IFN-c: 3.3, IL-1a: 8.6, IL-1b: 2.5, IL-2: 3.2, IL-3: 41.6, IL-4:
7.8, IL-5: 3.2, IL-6: 5.1, IL-7: 7.1, IL-8: 3.7, IL-10: 8.0, IL-
12(p40): 18.0, IL-12(p70): 6.9, IL-13: 10.1, IL-15: 1.8, IL-17: 3.4,
IP-10: 6.2, MCP-1: 5.3, MIP1-a: 3.4, MIP1-b: 7.3, TNF-a: 3.6,
and TNF-b: 3.4. Significant responses (defined with an asterisk in
figure 4A and graphed in figure 4B) were defined as average values
greater than the limit of detection with and less than 20% CV
value between duplicates. Undetectable levels from culture
supernatants were given an arbitrary value of zero and are located
on the Y axis in Figure 4A.
Flow cytometry to determine circulating NKT subset
distribution
PBMCs were incubated with CD1d-tetramer-PBS57, anti-CD3,
anti-CD56, anti-CD161, anti-CD4, Amine Aqua, anti-CD8, and
Ex vivo Human NKT Cell Functions
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washed twice with FACS buffer, and streptavidin-Qdot 655 was
added for 20–30 minutes at 4uC. Cells were washed twice with
FACS buffer, resuspended in 2% paraformaldehyde, and run on a
LSR-II Flow Cytometer (BD Biosciences, San Jose, CA, USA). All
cells were stained at a concentration of 1610
7 PBMC per 100 ml
of antibody mixtures in v-bottom 96 well plates. The data were
analyzed with FlowJo software (version 8.5.2, Tree Star, Ashland,
OR, USA). Gating and analysis of all data was performed without
knowledge of the subjects’ characteristics, including gender.
Statistical analysis
A two-tailed T test was used to determine significant differences
between groups in Figure 3, Figure 5A, Figure 6A, and Figure 6B.
A p value of ,0.05 was considered statistically significant.
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